NCT03038230
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03038230
Title MCLA-117 in Acute Myelogenous Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merus N.V.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | FRA | BEL

Facility Status City State Zip Country Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
The University of Texas, MD Anderson Cancer Center Houston Texas 77030 United States Details
Ziekenhuis Netwerk Antwerpen Campus Stuivenberg Antwerp 2060 Belgium Details
Institut Gustave Roussy Villejuif Île-de-France Region 94805 France Details
Fondazione Policlinico Tor Vergata Rome 00133 Italy Details
Amsterdam UMC, location VUmc Amsterdam North Holland 1081HV Netherlands Details
Erasmus MC Rotterdam South Holland Netherlands Details
Universitair Medisch Centrum Groningen Groningen Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field